1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Plasma Protease C1-inhibitor Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Plasma Protease C1-inhibitor Treatment Industry: Forecasts to 2025

  • October 2017
  • 254 pages
  • ID: 5207235
In this report:
Geographically, the global plasma protease C##-inhibitors treatment market has been categorized into four major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (EU-## Countries, BENELUX Countries, and Rest of Europe), Latin America (Brazil, Argentina, and Rest of Latin America) and Rest of World (Australia, Israel, and Rest of World Countries).

Summary

Table of Contents

Global Plasma Protease C1-inhibitor Treatment Market: Summary

This business report on the plasma protease C1-inhibitors treatment market examines the current and future scenario of the overall market. Big number of acute HAE patients is growing the usage of plasma protease C1-inhibitors treatment. Rising prevalence of rare diseases around the globe, promising pipeline drugs and novel therapies, growing investments in innovation of inhibitor drugs and growing HAE awareness programs are the main drivers of the overall plasma protease C1-inhibitors treatment market.

The plasma protease C1-inhibitors treatment market report comprises a detailed executive summary, which comprises a market snapshot that offers data about several segments of the market. It also offers info and data analysis of the overall market with respect to the segments established on drug class, dosage type, distribution channel and territory. A in-depth qualitative analysis of drivers and restraints of the market and alternatives has been specified in the market survey part. Additionally, the section comprises Porters Five Forces analysis to comprehend the ambitious landscape in the industry. This section of the report also offers Analysis of market appeal, by area and market share review by top players, thus presenting a comprehensive study of the overall competitive scenario in the global plasma protease C1-inhibitors treatment market.

Global Plasma Protease C1-inhibitor Treatment Market: Market Segmentation

Established on drug class, the sector has been broken down into C1-inhibitors (C1-esterase Inhibitor, Recombinant Inhibitor); Kallikrein Inhibitor ; Selective Bradykinin B2 Receptor Antagonist. The drug class market segments have been examined based on available approved products, cost-effectiveness, and preference given by the physicians for the treatment of HAE patients. The market value and estimate for each of these segments have been provided for the time span from 2015 to 2025, together with their respective CAGRs for the outlook period from 2017 to 2025, considering 2016 as the base year.

Established on distribution channel, the plasma protease C1-inhibitors treatment market has been split into four main categories: hospital pharmacies, and independent pharmacies & outlets. The plasma protease C1-inhibitors treatment market is also divided into dosage type lyophilized and liquid/injectable. The market segments have been comprehensively studied based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each division have been provided for the time span from 2015 to 2025. The market research also offers the CAGR for each market segment for the estimate period from 2017 to 2025, considering 2016 as the base year.

Geographically, the overall plasma protease C1-inhibitors treatment market has been classified into four main regions and the main countries in the respective region: North America continent, EU (EU-5 Countries, BENELUX Countries, and Rest of Europe (EU)), Latin America area (Brazil (BR), Argentina, and Rest of Latin America area) and Rest of World (Australia (AU), Israel, and Rest of World Countries). The market value and estimate for each of these regions and the mentioned countries have been provided for the time span from 2015 to 2025, together with their respective CAGRs for the outlook period from 2017 to 2025, considering 2016 as the base year. The business research study also includes the ambitious scenario in these areas.

Global Plasma Protease C1-inhibitor Treatment Market: Opposing landscape

The study also describes main actors in the overall plasma protease C1-inhibitors treatment segment based on several features such as corporate overview and financial analysis, product portfolio, strategic management, and recent evolutions. Main actors described in this study include Shire plc, CSL Limited, Sanquin and Pharming Group N.V.

Global Plasma Protease C1-inhibitors Treatment Market, By Geography

North America (NA)

USA

Canada (CA)

Europe (EU)

EU-5 Countries

BENELUX Countries

Rest of europe (EU)

Latin America

Argentina (AR)

Brazil (BR)

Rest of Latin America

Rest of World

Australia (AU)

Israel

Rest of World Countries

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026

Lipid Disorder Treatment Industry: Forecasts to 2026

  • $ 5795
  • Industry report
  • March 2018
  • by Transparency Market Research

Extensive research report on global lipid disorders treatment market skilfully crafted by Transparency Market Research depicts the current as well as future scenario of various drugs used to treat lipid ...

Injection Pen Market by Type, End User And Region - Global Forecast to 2022

Injection Pen Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • February 2018
  • by MarketsandMarkets

The injection pen market is projected to grow at a CAGR of 6.0% during the forecast periodThe global injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion ...

Addiction Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Addiction Treatment Industry: Forecasts to 2025

  • $ 5795
  • Industry report
  • February 2018
  • by Transparency Market Research

Global Addiction Treatment Market: OverviewThis report on the addiction treatment market analyzes the current and future scenario of the global market. Awareness initiatives by different drug manufacturers, ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on